Parallax Volatility Advisers, L.P. Boston Scientific Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $5.19 Million - $5.98 Million	-71,200 Reduced 44.39%	89,200 $7.47 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $74,063 - $85,481	-1,100 Reduced 0.68%	160,400 $12.4 Million
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $6.29 Million - $7.49 Million	109,200 Added 208.8%	161,500 $11.1 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $3.69 Million - $4.38 Million	-75,800 Reduced 59.17%	52,300 $3.02 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $5.86 Million - $6.38 Million	116,700 Added 1023.68%	128,100 $6.76 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $7.04 Million - $7.74 Million	-141,600 Reduced 92.55%	11,400 $616,000
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $2.14 Million - $2.38 Million	-47,500 Reduced 23.69%	153,000 $7.65 Million
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $1.54 Million - $1.84 Million	-39,000 Reduced 16.28%	200,500 $9.28 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $20.5 Million - $61.2 Million	-557,700 Reduced 69.96%	239,500 $9.28 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $26.4 Million - $35.3 Million	748,700 Added 1543.71%	797,200 $29.7 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $5.91 Million - $6.51 Million	-144,400 Reduced 74.86%	48,500 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $1.91 Million - $2.25 Million	50,200 Added 35.18%	192,900 $8.19 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $5.24 Million - $5.83 Million	-127,000 Reduced 47.09%	142,700 $6.19 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $1.22 Million - $1.4 Million	31,600 Added 13.27%	269,700 $11.5 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $726,562 - $817,202	-20,600 Reduced 7.96%	238,100 $9.2 Million
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $6.26 Million - $7.92 Million	-188,700 Reduced 42.18%	258,700 $9.3 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $2.47 Million - $3.02 Million	71,600 Added 19.05%	447,400 $17.1 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $9.53 Million - $12.4 Million	315,800 Added 526.33%	375,800 $13.2 Million
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $8 Million - $14.2 Million	-309,700 Reduced 83.77%	60,000 $1.96 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $5.48 Million - $6.57 Million	-144,700 Reduced 28.13%	369,700 $16.7 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $15.2 Million - $16.3 Million	376,200 Added 272.21%	514,400 $20.9 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $3.15 Million - $3.88 Million	-90,300 Reduced 39.52%	138,200 $5.94 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $5.6 Million - $6.94 Million	170,200 Added 291.94%	228,500 $8.77 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $1.42 Million - $1.75 Million	-44,800 Reduced 43.45%	58,300 $2.06 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $3.38 Million - $3.98 Million	103,100 New	103,100 $3.97 Million

Others Institutions Holding BSX

# of Institutions

1,537

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

Vanguard Group Inc Valley Forge, PA

131M
Shares

$11.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

126M
Shares

$11 Billion
0.22% of portfolio
State Street Corp Boston, MA

62.8M
Shares

$5.47 Billion
0.22% of portfolio
Primecap Management CO Pasadena, CA

37.8M
Shares

$3.29 Billion
2.37% of portfolio
Wellington Management Group LLP Boston, MA

32.8M
Shares

$2.86 Billion
0.49% of portfolio

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $125B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account